tm logo
TEGEMUNIN
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 10 Jun 2016

Last Applicant/ Owned by

Josef-Engert-Str. 9

Regensburg

DE

93053

Serial Number

77117385 filed on 27th Feb 2007

Registration Number

3703948 registered on 03rd Nov 2009

in the Principal Register

Correspondent Address

Lawrence E. Abelman

LAWRENCE E. ABELMAN

666 3RD AVE

NEW YORK, NY 10017-4011

Filing Basis

1. intent to use

Disclaimer

NO DATA

TEGEMUNIN

Pharmaceutical drugs for the treatment of neoplasms, for the treatment of immunosuppresive disorders, for the treatment of fibrotic disorders, for the treatment of disorders of scarring, for the treatment of disorders of wound healing Medical, diagnostic and scientific research in the field of the cause and progression of diseases and design and development of drugs to combat such diseases

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical drugs for the treatment of neoplasms, for the treatment of immunosuppresive disorders, for the treatment of fibrotic disorders, for the treatment of disorders of scarring, for the treatment of disorders of wound healing

Class [042]
Computer & Software Services & Scientific Services


Medical, diagnostic and scientific research in the field of the cause and progression of diseases and design and development of drugs to combat such diseases

Mark Details


Serial Number

No 77117385

Mark Type

No Service Mark

Attorney Docket Number

No 872163

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Jun 2016CANCELLED SEC. 8 (6-YR)
03rd Nov 2009REGISTERED-PRINCIPAL REGISTER
18th Aug 2009PUBLISHED FOR OPPOSITION
29th Jul 2009NOTICE OF PUBLICATION
15th Jul 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
14th Jul 2009ASSIGNED TO LIE
09th Jul 2009APPROVED FOR PUB - PRINCIPAL REGISTER
08th Jul 2009TEAS/EMAIL CORRESPONDENCE ENTERED
08th Jul 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
08th Jul 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED